26 results on '"Elneil, Sohier"'
Search Results
2. The Benefits and Harms of Pharmacological Treatment for Postradiation Pelvic Pain: A Systematic Review by the European Association of Urology Chronic Pelvic Pain Panel with Recommendations for Clinical Practice
3. Myofascial Pelvic Pain: Best Orientation and Clinical Practice. Position of the European Association of Urology Guidelines Panel on Chronic Pelvic Pain
4. The Benefits and Harms of Botulinum Toxin-A in the Treatment of Chronic Pelvic Pain Syndromes: A Systematic Review by the European Association of Urology Chronic Pelvic Pain Panel
5. Gynaecological pathology in women with Fowler's syndrome
6. Global efforts for effective training in fistula surgery
7. Sacral Neuromodulation Outcomes in Male Patients with Chronic Urinary Retention
8. Optimizing the Duration of Assessment of Stage-1 Sacral Neuromodulation in Nonobstructive Chronic Urinary Retention
9. The Possible Role of Opiates in Women with Chronic Urinary Retention: Observations from a Prospective Clinical Study
10. Long-Term Effect on Quality of Life of Repeat Detrusor Injections of Botulinum Neurotoxin-A for Detrusor Overactivity in Patients With Multiple Sclerosis
11. Complete Continence after Botulinum Neurotoxin Type A Injections for Refractory Idiopathic Detrusor Overactivity Incontinence: Patient-Reported Outcome at 4 Weeks
12. In the Human Urothelium and Suburothelium, Intradetrusor Botulinum Neurotoxin Type A Does Not Induce Apoptosis: Preliminary Results
13. EAU Guidelines on Chronic Pelvic Pain
14. Immunohistochemical Expression of Muscarinic Receptors in the Urothelium and Suburothelium of Neurogenic and Idiopathic Overactive Human Bladders, and Changes With Botulinum Neurotoxin Administration
15. Cadherin-11 Up-Regulation in Overactive Bladder Suburothelial Myofibroblasts
16. Suburothelial Myofibroblasts in the Human Overactive Bladder and the Effect of Botulinum Neurotoxin Type A Treatment
17. Complex pelvic floor failure and associated problems
18. Recommendations on the Use of Botulinum Toxin in the Treatment of Lower Urinary Tract Disorders and Pelvic Floor Dysfunctions: A European Consensus Report
19. What a Patient With Refractory Idiopathic Detrusor Overactivity Should Know About Botulinum Neurotoxin Type A Injection
20. Early Effect on the Overactive Bladder Symptoms following Botulinum Neurotoxin Type A Injections for Detrusor Overactivity
21. Histological Changes in the Urothelium and Suburothelium of Human Overactive Bladder following Intradetrusor Injections of Botulinum Neurotoxin Type A for the Treatment of Neurogenic or Idiopathic Detrusor Overactivity
22. Activation of epithelial Na + channel activity in the rabbit urinary bladder by cAMP
23. Case study of a critically ill person with COVID-19 on ECMO successfully treated with leronlimab
24. CHOLINERGIC SIGNALLING PATHWAYS IN THE SUPERFICIAL LAYERS OF THE HUMAN BLADDER; COMPARING HEALTH, DISEASE AND THE EFFECT OF BOTULINUM TOXIN TYPE A
25. PERIODIC INTRA-DETRUSOR INJECTIONS OF BOTULINUM NEUROTOXIN TYPE-A IN PATIENTS WITH INTRACTABLE DETRUSOR OVERACTIVITY
26. 1184: 10-Year Experience of Sacral Neuromodulation in Urinary Retention - Results from UK Tertiary Referral Centre
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.